Hand-Foot-Mouth Disease (Coxsackievirus Type A)
Overview
Plain-Language Overview
Hand-Foot-Mouth Disease (HFMD) is a common viral illness that mainly affects young children. It primarily involves the skin and mucous membranes, causing a rash on the hands, feet, and inside the mouth. The disease is caused by infection with Coxsackievirus Type A, which spreads easily through close contact and respiratory droplets. Symptoms include fever, painful mouth sores, and a characteristic rash with small blisters. Although uncomfortable, HFMD usually resolves on its own without serious complications. The illness mainly impacts the skin and oral cavity, affecting eating and comfort during the acute phase.
Clinical Definition
Hand-Foot-Mouth Disease (HFMD) is an acute, self-limited viral illness caused predominantly by Coxsackievirus A16 and other enteroviruses. It is characterized by a distinctive clinical syndrome involving vesicular eruptions on the palms, soles, and oral mucosa. The pathogenesis involves viral replication in the oropharynx and gastrointestinal tract, followed by viremia and dissemination to the skin and mucous membranes. The disease primarily affects children under 5 years old and is highly contagious through fecal-oral and respiratory routes. Clinically, HFMD presents with fever, malaise, and painful oral ulcers, followed by a vesicular rash that may cause discomfort but rarely leads to severe complications. Diagnosis is mainly clinical, supported by epidemiologic context and characteristic lesions.
Inciting Event
Infection with Coxsackievirus A16 or other enteroviruses initiates disease.
Exposure to contaminated respiratory secretions or feces triggers infection.
Contact with contaminated surfaces or fomites can lead to viral transmission.
Latency Period
Incubation period of 3 to 6 days occurs between viral exposure and symptom onset.
Viremia develops within days after initial mucosal infection before rash appears.
Diagnostic Delay
Mild initial symptoms resembling common viral illnesses can delay recognition.
Misattribution of oral ulcers to aphthous stomatitis leads to missed diagnosis.
Lack of awareness of characteristic rash distribution may cause diagnostic uncertainty.
Clinical Presentation
Signs & Symptoms
Fever and malaise typically precede rash onset by 1-2 days.
Painful oral ulcers cause difficulty eating and drooling in young children.
Vesicular rash on the palms, soles, and sometimes buttocks is the hallmark presentation.
Sore throat and irritability are common early symptoms.
History of Present Illness
Prodrome of low-grade fever and malaise precedes rash by 1-2 days.
Painful oral vesicles and ulcers develop on the buccal mucosa, tongue, and palate.
Vesicular rash appears on the palms, soles, and sometimes buttocks within 1-2 days after oral lesions.
Symptoms typically resolve within 7 to 10 days without complications.
Past Medical History
No specific prior conditions are required for susceptibility, but immunodeficiency may worsen course.
Recent exposure to infected individuals or attendance at group childcare is relevant.
No history of chronic skin or mucosal diseases is typical.
Family History
There is no known hereditary predisposition to hand-foot-mouth disease.
Family members may be affected due to close contact and shared environment.
No familial syndromes are associated with susceptibility to Coxsackievirus infection.
Physical Exam Findings
Multiple painful vesicular lesions on the palms, soles, and oral mucosa are characteristic.
Erythematous maculopapular rash may be present on the buttocks and genitalia.
Oral ulcers with erythematous halos are commonly observed on the tongue and buccal mucosa.
Low-grade fever and mild cervical lymphadenopathy may be noted on examination.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of hand-foot-mouth disease is primarily clinical, based on the presence of fever, characteristic vesicular lesions on the palms, soles, and oral mucosa, and a compatible epidemiologic history. The hallmark findings include painful oral ulcers and a non-itchy vesicular rash localized to the hands and feet. Laboratory confirmation can be obtained by viral culture or PCR of throat swabs or vesicle fluid, but these are not routinely required. Differential diagnosis includes varicella and herpangina, which can be distinguished by lesion distribution and clinical features.
Pathophysiology
Key Mechanisms
Enteroviral infection of mucosal epithelial cells initiates local inflammation and vesicular lesions.
Viral replication in the oropharynx and gastrointestinal tract leads to systemic viremia.
Immune response causes characteristic vesicular rash and oral ulcers due to cytotoxic effects on epithelial cells.
Transmission via fecal-oral and respiratory droplets facilitates spread and reinfection.
| Involvement | Details |
|---|---|
| Organs | Skin is affected by characteristic vesicular rash on the hands, feet, and sometimes buttocks. |
Oral cavity develops painful vesicles and ulcers that impair feeding and hydration. | |
Lymph nodes may become mildly enlarged due to immune activation during infection. | |
| Tissues | Epidermal tissue is the primary site of vesicular lesion formation in hand-foot-mouth disease. |
Oral mucosa tissue is involved in painful ulcerative lesions characteristic of the disease. | |
| Cells | Keratinocytes are infected by Coxsackievirus A, leading to vesicular lesions on the skin and oral mucosa. |
Langerhans cells participate in antigen presentation and initiate the immune response against the virus. | |
T lymphocytes mediate the cellular immune response contributing to lesion resolution. | |
| Chemical Mediators | Interleukin-1 (IL-1) is released by infected cells and promotes local inflammation and fever. |
Tumor necrosis factor-alpha (TNF-α) contributes to the inflammatory response and tissue damage in affected areas. | |
Interferons are produced as part of the antiviral immune response limiting viral replication. |
Treatments
Pharmacological Treatments
Acetaminophen
- Mechanism:
Inhibits central prostaglandin synthesis to reduce fever and pain.
- Side effects:
Hepatotoxicity with overdose
Allergic reactions
- Clinical role:
First-line
Ibuprofen
- Mechanism:
Nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes to reduce inflammation, fever, and pain.
- Side effects:
Gastrointestinal irritation
Renal impairment
Allergic reactions
- Clinical role:
First-line
Non-pharmacological Treatments
Maintain adequate hydration with oral fluids to prevent dehydration from oral ulcers.
Use soft, bland foods to minimize oral mucosa irritation during eating.
Practice good hand hygiene to reduce transmission of Coxsackievirus A.
Prevention
Pharmacological Prevention
No approved antiviral prophylaxis exists for hand-foot-mouth disease.
Experimental vaccines targeting Coxsackievirus A16 are under investigation but not yet available.
Non-pharmacological Prevention
Hand hygiene with soap and water is critical to reduce transmission.
Avoidance of close contact with infected individuals during the contagious period prevents spread.
Disinfection of contaminated surfaces and toys reduces environmental viral load.
Isolation of affected children from daycare or school settings during acute illness limits outbreaks.
Outcome & Complications
Complications
Dehydration from painful oral ulcers leading to poor oral intake is the most frequent complication.
Viral meningitis can rarely occur, presenting with headache and neck stiffness.
Nail shedding (onychomadesis) may develop weeks after acute illness.
Secondary bacterial superinfection of skin lesions can cause cellulitis.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Hand-Foot-Mouth Disease (Coxsackievirus Type A) versus Herpangina
Hand-Foot-Mouth Disease (Coxsackievirus Type A) | Herpangina |
|---|---|
Caused primarily by Coxsackievirus type A | Caused primarily by Coxsackievirus types A and B |
Vesicular lesions on hands, feet, and oral mucosa including anterior mouth | Vesicular lesions localized to the posterior oropharynx (soft palate, tonsillar pillars) |
Fever with characteristic rash on hands and feet | Fever and sore throat without rash on extremities |
Hand-Foot-Mouth Disease (Coxsackievirus Type A) versus Varicella (Chickenpox)
Hand-Foot-Mouth Disease (Coxsackievirus Type A) | Varicella (Chickenpox) |
|---|---|
Non-pruritic vesicles with erythematous halo, uniform stage | Pruritic vesicles in various stages of healing (dew drop on rose petal) |
Vesicular rash localized to hands, feet, and oral mucosa | Generalized vesicular rash including trunk and face |
Exposure to individuals with hand, foot, and mouth lesions | Exposure to individuals with generalized vesicular rash |
Hand-Foot-Mouth Disease (Coxsackievirus Type A) versus Herpes Simplex Virus (HSV) Infection
Hand-Foot-Mouth Disease (Coxsackievirus Type A) | Herpes Simplex Virus (HSV) Infection |
|---|---|
Vesicles on hands, feet, and oral mucosa including buccal mucosa | Painful grouped vesicles primarily on lips or genitalia |
Usually a single self-limited episode | Recurrent episodes common |
Positive PCR or culture for Coxsackievirus type A | Positive PCR or culture for HSV |
Hand-Foot-Mouth Disease (Coxsackievirus Type A) versus Kawasaki Disease
Hand-Foot-Mouth Disease (Coxsackievirus Type A) | Kawasaki Disease |
|---|---|
Vesicular rash on hands, feet, and oral mucosa | Polymorphous rash without vesicles |
Mild fever, no conjunctivitis or lymphadenopathy | Prolonged fever >5 days, conjunctivitis, lymphadenopathy |
Self-limited, supportive care only | Responds to intravenous immunoglobulin and aspirin |
Hand-Foot-Mouth Disease (Coxsackievirus Type A) versus Secondary Syphilis
Hand-Foot-Mouth Disease (Coxsackievirus Type A) | Secondary Syphilis |
|---|---|
Vesicular rash localized to hands, feet, and oral mucosa | Symmetric maculopapular rash involving palms and soles |
No generalized lymphadenopathy or mucous patches | Generalized lymphadenopathy and mucous patches |
Positive Coxsackievirus PCR or culture | Positive treponemal serology |